These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9862214

  • 1. Identification of two new hydrophobic residues on basic fibroblast growth factor important for fibroblast growth factor receptor binding.
    Zhu H, Ramnarayan K, Menzel P, Miao Y, Zheng J, Mong S.
    Protein Eng; 1998 Oct; 11(10):937-40. PubMed ID: 9862214
    [Abstract] [Full Text] [Related]

  • 2. Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor.
    Zhu H, Anchin J, Ramnarayan K, Zheng J, Kawai T, Mong S, Wolff ME.
    Protein Eng; 1997 Apr; 10(4):417-21. PubMed ID: 9194167
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.
    Springer BA, Pantoliano MW, Barbera FA, Gunyuzlu PL, Thompson LD, Herblin WF, Rosenfeld SA, Book GW.
    J Biol Chem; 1994 Oct 28; 269(43):26879-84. PubMed ID: 7929426
    [Abstract] [Full Text] [Related]

  • 5. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD, Pantoliano MW, Springer BA.
    Biochemistry; 1994 Apr 05; 33(13):3831-40. PubMed ID: 8142385
    [Abstract] [Full Text] [Related]

  • 6. Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
    Patrie KM, Botelho MJ, Franklin K, Chiu IM.
    Biochemistry; 1999 Jul 20; 38(29):9264-72. PubMed ID: 10413500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.
    Heath WF, Cantrell AS, Mayne NG, Jaskunas SR.
    Biochemistry; 1991 Jun 04; 30(22):5608-15. PubMed ID: 2036431
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand-receptor interaction.
    Chaudhuri MM, Moscatelli D, Basilico C.
    J Cell Physiol; 1993 Nov 04; 157(2):209-16. PubMed ID: 8227155
    [Abstract] [Full Text] [Related]

  • 11. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR, Matsunami RK, Engler DA, Niyogi SK.
    Biochemistry; 1990 Oct 23; 29(42):9988-93. PubMed ID: 2271634
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
    Rusnati M, Coltrini D, Caccia P, Dell'Era P, Zoppetti G, Oreste P, Valsasina B, Presta M.
    Biochem Biophys Res Commun; 1994 Aug 30; 203(1):450-8. PubMed ID: 8074689
    [Abstract] [Full Text] [Related]

  • 14. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.
    Isacchi A, Statuto M, Chiesa R, Bergonzoni L, Rusnati M, Sarmientos P, Ragnotti G, Presta M.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2628-32. PubMed ID: 1849269
    [Abstract] [Full Text] [Related]

  • 15. The role of heparin in the complex formation between fibroblast growth factor 2 and its high affinity receptor: comparative modelling and biochemical studies.
    Pellegrini L, Commander P, Mulloy B, Martin-Martinez M, Blundell TL, Burke DF.
    Biochem Soc Trans; 1998 Aug 01; 26(3):545-9. PubMed ID: 9765911
    [No Abstract] [Full Text] [Related]

  • 16. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I.
    J Cell Biochem; 1995 Feb 01; 57(2):173-84. PubMed ID: 7759555
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
    Steinfeld R, Van Den Berghe H, David G.
    J Cell Biol; 1996 Apr 01; 133(2):405-16. PubMed ID: 8609172
    [Abstract] [Full Text] [Related]

  • 18. Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors.
    Gray TE, Eisenstein M, Shimon T, Givol D, Yayon A.
    Biochemistry; 1995 Aug 22; 34(33):10325-33. PubMed ID: 7544612
    [Abstract] [Full Text] [Related]

  • 19. Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence.
    Presta M, Gualandris A, Urbinati C, Rusnati M, Coltrini D, Isacchi A, Caccia P, Bergonzoni L.
    Growth Factors; 1993 Aug 22; 9(4):269-78. PubMed ID: 8148156
    [Abstract] [Full Text] [Related]

  • 20. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K, Rao VS, Qasba PK.
    J Biomol Struct Dyn; 1998 Jun 22; 15(6):1009-27. PubMed ID: 9669548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.